Plasma hydrogen sulfide: A biomarker of Alzheimer's disease and related dementias
Elizabeth A. Disbrow, Karen Y. Stokes, Christina Ledbetter, James C. Patterson, Roger E. Kelley, Sibile Pardue, Tyler H. Reekes, Lana Larmeu, Vinita Batra, Shuai Yuan, Urška Cvek, Marjan Trutschl, Phillip Kilgore, J. Steven Alexander, Christopher G. Kevil
Abstract
Abstract While heart disease remains a common cause of mortality, cerebrovascular disease also increases with age, and has been implicated in Alzheimer's disease and related dementias (ADRD). We have described hydrogen sulfide (H 2 S), a signaling molecule important in vascular homeostasis, as a biomarker of cardiovascular disease. We hypothesize that plasma H 2 S and its metabolites also relate to vascular and cognitive dysfunction in ADRD. We used analytical biochemical methods to measure plasma H 2 S metabolites and MRI to evaluate indicators of microvascular disease in ADRD. Levels of total H 2 S and specific metabolites were increased in ADRD versus controls. Cognition and microvascular disease indices were correlated with H 2 S levels. Total plasma sulfide was the strongest indicator of ADRD, and partially drove the relationship between cognitive dysfunction and white matter lesion volume, an indicator of microvascular disease. Our findings show that H 2 S is dysregulated in dementia, providing a potential biomarker for diagnosis and intervention.